3-tyr-octreotide has been researched along with calcimycin in 1 studies
| Studies (3-tyr-octreotide) | Trials (3-tyr-octreotide) | Recent Studies (post-2010) (3-tyr-octreotide) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 95 | 2 | 4 | 11,946 | 40 | 444 |
| Protein | Taxonomy | 3-tyr-octreotide (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, J; Shi, Y; Shu, C; Yin, J | 1 |
1 other study(ies) available for 3-tyr-octreotide and calcimycin
| Article | Year |
|---|---|
[The role of Ca2+ in the pathogenesis of human pituitary GH-secreting adenomas].
Topics: Adenoma; Biological Transport, Active; Calcimycin; Calcium; Calcium Channel Blockers; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Ionophores; Nicardipine; Nifedipine; Octreotide; Pituitary Neoplasms; Somatostatin; Tumor Cells, Cultured | 1996 |